1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量：1518
2Guzzaloni G, Grugni G, Minocci A, et al. Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes Relat Metab Disord,2000,24:772-776.
3Rocha R, Cotrim HP, Carvalho FM, et al. Body mass index and waist circumference in non-alcoholic fatty liver disease. J Hum Nutr Diet,2005,18:365-370.
4Venturi C, Zoppini G, Zamboni C, et al. Insulin sensitivity and hepatic steatosis in obese subjects with normal glucose tolerance.Nutr Metab Cardiovasc Dis, 2004,14:200-204.
5Sargin M, Uygur-Bayramicli O, Sargin H, et al. Association of nonalcoholic fatty liver disease with insulin resistance: is OGTT indicated in nonalcoholic fatty liver disease? J Clin Gastroenterol,2003,37:399-402.
6Angelico F, Del Ben M, Conti R, et al. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab, 2005,90 : 1578-1582.
7Targher G, Bertolini L, Padovani R. Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in dietcontrolled type 2 diabetic patients. J Endocrinol Invest, 2006,29 :55-60.
8Villanova N, Moscatlello S, Ramilli S, et aL Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology, 2005,42:473-480.
9Alessi MC, Bastelica D, Mavri A, et al. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation. Arterioscler Thromb Vase Biol, 2003,23: 1262-1268.
5Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.
6Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490.
7Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44.
8Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261.
10Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.
